Grant funds new approach to HIV vaccine
June 3, 2014Using a genetically modified form of the HIV virus, a team of UNL scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine. The team has received a $1.9 million grant from the National Institutes of Health and National Institute of Allergy and Infectious Diseases to further the project toward animal trials.